about
Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation.External hemipelvectomy as treatment for solitary coxofemoral metastasis from endometrial carcinoma: case report and review of the literature.Total Laparoscopic Hysterectomy With Percutaneous (Percuvance) Instruments: New Frontier of Minimally Invasive Gynecological Surgery.Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study.Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome.Telelap ALF-X vs Standard Laparoscopy for the Treatment of Early-Stage Endometrial Cancer: A Single-Institution Retrospective Cohort Study.Telelap Alf-X-Assisted Laparoscopy for Ovarian Cyst Enucleation: Report of the First 10 Cases.Laparoscopic Splenectomy for Secondary Cytoreduction in Ovarian Cancer Patients With Localized Spleen Recurrence: Feasibility and Technique.Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC).TELELAP ALF-X Robotic-assisted Laparoscopic Hysterectomy: Feasibility and Perioperative Outcomes.Metformin improves endothelial function in normoinsulinemic PCOS patients: a new prospective.Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin.Fasting and post-methionine homocysteine levels in Alzheimers disease and vascular dementia.Ovarian cancer patients with localized relapse: clinical outcome and prognostic factors.Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery?Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome.Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery.Minilaparoscopic versus single-port total hysterectomy: a randomized trial.The differential effect of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women: relationship with the metabolic status.Low- and standard-estrogen dosage in oral therapy: dose-dependent effects on insulin and lipid metabolism in healthy postmenopausal women.Laparoscopic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study.Learning a new robotic surgical device: Telelap Alf X in gynaecological surgery.Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes.Early postoperative bladder training in patients submitted to radical hysterectomy: is it still necessary? A randomized trial.Urologic surgery in gynecologic oncology: a large single-institution experience.Randomized study comparing use of THUNDERBEAT technology vs standard electrosurgery during laparoscopic radical hysterectomy and pelvic lymphadenectomy for gynecologic cancer.HIPEC in recurrent ovarian cancer patients: morbidity-related treatment and long-term analysis of clinical outcome.Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer.Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case-control study on survival in patients with two year follow-up.Positron emission tomography-laparoscopy based method in the prediction of complete cytoreduction in platinum-sensitive recurrent ovarian cancer.Estro-progestin supplementation enhances the growth hormone secretory responsiveness to ghrelin infusion in postmenopausal women.Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series.Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndromeComparison of optimal cytoreduction rates in emergency versus non-emergency admissions for advanced ovarian cancer: a multi-institutional studyThe new robotic TELELAP ALF-X in gynecological surgery: single-center experienceLaparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experienceInfluence of intraperitoneal dissemination assessed by laparoscopy on prognosis of advanced ovarian cancer: an exploratory analysis of a single-institution experience
P50
Q36740468-610F9680-7DA5-416B-8AD3-A7124846538DQ37993173-36AD9389-0569-40CB-B7A4-50A8A85F343EQ38589549-59C5E91B-ED6C-4B07-A781-F8AA99CCB4AEQ38623416-03B5A8BC-05BD-4B6C-91E5-92326580FE2EQ39902180-490A3104-F41D-4F19-9F5E-F7992952FE36Q40280680-B7FFED5B-808A-4D14-A333-17FC039629C6Q40925694-00879488-A394-405E-88D8-24DF71317B54Q40970980-BD581A8B-CDF1-41CB-B8E4-B2CB52B6274DQ41012742-83844D51-076B-4475-BB0A-EA85FDAA46D5Q41732794-2C9962DB-C482-441E-A52D-33C4F0D7CCA9Q42437662-4C879FE2-21BF-4EEA-9031-9A322A128CC8Q42507854-17ED3D39-AED7-4524-9EAE-9E82EBB71BC0Q43139959-7D532524-C77F-442A-AC69-1B3F29E3708DQ43649815-49C65B96-231E-4DEB-97A2-1608A524BC6BQ44039567-F6C1CAFA-D600-4FF2-A5ED-414C729EE671Q44785371-A9DC3D63-1211-44FD-ACAE-D17926536810Q45100753-9D5D5923-E718-4FB0-BB68-0A4CBD86F46AQ45394953-509DF073-8A9A-4019-9696-088E76190DD8Q46239516-EFBF73CE-4028-42E9-9660-88B78B7BF61EQ46259264-FA25DE35-9F39-465F-AA8E-A461F73A6064Q50558614-5018695C-8A7F-4E63-B631-F4EE136CB0CDQ50581489-FB86FA48-C4A1-44FD-9206-71081C08191CQ50606024-D51B0E75-7595-4035-A9C5-A7E10A156A9FQ50626884-6AAE6EDC-660D-444C-B0E8-53CEC83C8802Q50710024-51A6DAB3-2669-42CB-8310-6841FE91E18BQ50745850-471E23DA-693E-46F4-B3DE-3D3E4771188AQ50788596-DC535376-C5DD-4DB9-8166-52F33842ACB5Q50789170-2798B984-599B-4DD2-8ABA-DD08087CEE11Q50794640-C3D2BA7D-C954-4F7C-B6CD-CA02ECA48107Q51050471-BC234EE4-5456-4E35-B2E4-3413557A2ED0Q51471184-B844F555-7F59-41F1-84E3-FECE0F51F709Q53084459-CCFDAC59-98B8-4291-9BA4-1108782D4001Q79871406-04395F63-C739-4903-A5CB-E18710FD91F9Q86934255-993FFA1B-1F01-40FE-B4F5-60B1C5EA8205Q87052322-3327B6E4-7B91-40D9-9F16-D0DDD1E5760FQ87079744-EE3197CE-F3C2-4FCE-9233-2BCE590A3AC4Q87923473-00E0C716-280A-4E76-82F2-D04F913B75B0
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
B Costantini
@ast
B Costantini
@en
B Costantini
@es
B Costantini
@nl
type
label
B Costantini
@ast
B Costantini
@en
B Costantini
@es
B Costantini
@nl
prefLabel
B Costantini
@ast
B Costantini
@en
B Costantini
@es
B Costantini
@nl
P106
P1153
36766383800
P31
P496
0000-0002-1414-0106